Alan Leung
About Alan Leung
Alan Leung serves as the Director of DNA Read-Write and Library Sciences at Generate:Biomedicines, bringing extensive experience in molecular biology and biotechnology. He holds a Ph.D. in Chemical Engineering from Stanford University and has worked in various scientific roles, including positions at Compass Therapeutics LLC and Stanford University.
Current Role at Generate Biomedicines
Alan Leung serves as the Director of DNA Read-Write and Library Sciences at Generate Biomedicines. He has held this position since 2024, overseeing initiatives related to DNA synthesis and library development. His role involves leading research efforts that leverage advanced molecular biology techniques to enhance biomedicine applications.
Professional Experience at Generate Biomedicines
Prior to his current role, Alan Leung worked at Generate Biomedicines as Associate Director of DNA Read-Write and Library Sciences from 2023 to 2024. He also served as Principal Scientist in Protein Engineering from 2021 to 2023. His contributions to the organization include advancing methodologies in DNA manipulation and protein engineering.
Career Background at Compass Therapeutics LLC
Alan Leung has a significant background at Compass Therapeutics LLC, where he held multiple positions from 2015 to 2019. He started as Scientist I, then progressed to Scientist II, and briefly served as Senior Scientist. His work focused on molecular biology and biotechnology, utilizing techniques such as next-generation sequencing.
Educational Qualifications
Alan Leung earned his Ph.D. in Chemical Engineering from Stanford University, where he studied from 2010 to 2015. He also completed a Bachelor of Science in Chemical Engineering and Biology at the Massachusetts Institute of Technology from 2006 to 2010. Additionally, he participated in the Stanford Ignite program, obtaining a certificate in Innovation and Entrepreneurship.
Research Contributions and Expertise
Alan Leung possesses advanced skills in flow cytometry and cell sorting, which are essential for molecular biology research. He has extensive experience in next-generation sequencing (NGS) and is proficient in mammalian and yeast display techniques. He contributed as an author to a research article on Chroma, a generative model for protein design.